Nanotherapeutics Awarded $20 Million NIAID/BARDA Contract to Develop Inhaled Gentamicin for Treatmen(...)
Nanotherapeutics, Inc., today announced that it has been awarded a $20 Million 4-year contract from the National Institute of Allergy and Infectious Diseases to develop an inhaled version of the injectable drug, gentamicin, a broad-spectrum antibiotic that is used as a first-line therapy for pneumonic plague and tularemia, Category A bioterrorism agents.
Posted: Oct 11th, 2007
Read moreNanoBioNexus Amongst Circle of International Government and Industry Leaders Catalyzing Innovation
Non-profit NanoBioNexus (NBN) - already widely acclaimed for its educational forums and nanobiotechnology expertise in the United States, has moved into the international leadership circles for innovative technologies with its International Alliance Initiative.
Posted: Oct 11th, 2007
Read moreNew Awards for Gulf Coast Companies by the Texas Emerging Technology Fund
Houston Technology Center and Gulf Coast RCIC honored the nine Gulf Coast region companies that received awards from the ETF to date. Total ETF funding thus far to Gulf Coast region companies is over $13 million.
Posted: Oct 11th, 2007
Read moreEnable IPC Corporation Ultracapacitor Delivers Twice the Expected Capacitance
Enable IPC Corporation announced that the continuing development of the ultracapacitor product has resulted in a device that delivers more than twice the expected capacitance.
Posted: Oct 11th, 2007
Read moreAspen Aerogels to Insulate 21-Kilometer Deep Sea Gas Pipeline in Brazil Spaceloft Insulation Saves Steel Costs, Space, and Installation Time
Aspen Aerogels has been awarded a contract to supply its advanced Spaceloft aerogel insulation for a 21-kilometer, undersea natural gas pipeline being built by Technip for Petrobras in Brazil.
Posted: Oct 11th, 2007
Read morePiedmont Triad Partnership Awards Seven New WIRED Focus Grants
The Piedmont Triad Partnership has awarded seven new Focus Grants in three categories under the WIRED Focus Grants program. The grants program is one of several strategies being employed by the PTP to enhance workforce development initiatives as part of a larger effort to improve the global competitiveness of the Piedmont Triad Region.
Posted: Oct 10th, 2007
Read moreAMAG Pharmaceuticals, Inc. Announces Eight Abstracts on Ferumoxytol to Be Presented at Upcoming American Society of Nephrology Meeting
Pharmaceuticals, Inc., a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia, today announced that eight abstracts on ferumoxtytol, its lead product candidate, have been accepted for presentation at the American Society of Nephrology meeting.
Posted: Oct 10th, 2007
Read moreIVAM updates success story - Product Market 'Micro, Nano & Materials' at MicroTechnology/Hannover Me(...)
Registrations for the Product Market 'Micro, Nano & Materials' at MicroTechnology/HANNOVER MESSE 2008 can now be addressed to IVAM.
Posted: Oct 10th, 2007
Read moreGenetic Immunity Closes $2 Million Dollar Bridge Financing
Genetic Immunity LLC, a clinical stage biopharmaceutical company and a leader in the development of DNA based nanoparticle immunotherapies, announced today the completion of a $2 million dollar bridge financing.
Posted: Oct 10th, 2007
Read moreBCC Research Report Says Global Market for Microscopes, Accessories and Supplies to Reach $3.6 Billion by 2012
According to a recently published BCC Research report, MICROSCOPY: THE GLOBAL MARKET (IAS017B), the global market for microscopes and accessories was worth about $2.1 billion in 2006.
Posted: Oct 10th, 2007
Read moreSurrey NanoSystems wins order for advanced sputtering tool from Poland's Institute of Electron Technology
Surrey NanoSystems has won an order for its Gamma 1000 thin-film sputtering tool, from Poland's Institute of Electron Technology.
Posted: Oct 10th, 2007
Read moreChemi Nutra Introduces Novel, Water Dispersible Phosphatidylserine For Functional Beverages
Chemi Nutra proudly announces the introduction of SerinAid Disperse 1.5F, a novel, water dispersible PS, designed for use in functional beverages.
Posted: Oct 9th, 2007
Read moreAccelrys Releases New and Enhanced Scripting and Workflow Capabilities in Materials Studio 4.2
Accelrys, Inc. today announced the release of Materials Studio 4.2, the newest version of its chemicals, materials and pharmaceutical development modeling and simulation platform.
Posted: Oct 9th, 2007
Read moreJPK Instruments Continues to Expand - Production Capacity Extended to Meet Increasing Sales Volume
JPK Instruments, the market leader in BioSPM, has further expanded the premises of its Berlin headquarters to take account of the continuing growth in personnel and the increasing demand for JPK products.
Posted: Oct 9th, 2007
Read moreNaturalNano Secures Exclusive License Agreement with U.S. Naval Research Laboratory
NaturalNano, Inc., a developer of advanced nanomaterials and additive technologies, announced it has signed an exclusive licensing agreement with the U.S. Naval Research Laboratory spanning multiple industries and broad patents in controlled-release nanomaterials.
Posted: Oct 9th, 2007
Read moreInsert Therapeutics' Lead Anti-Cancer Compound is Highlighted in Public Television Documentary
Insert Therapeutics, Inc., a majority-owned subsidiary of Arrowhead Research Corporation, announced today that its lead anti-cancer compound, IT-101, will be featured in a public television documentary series produced by Thirteen/WNET New York and the California Institute of Technology (Caltech).
Posted: Oct 9th, 2007
Read more